Minimally invasive surgeries (e.g., laparoscopic or robotic surgeries) have been accepted and standardized as safe procedures, with comparable or better results compared to conventional open surgeries for managing various diseases of the intraabdominal organs. Likewise, the laparoscopic approach for the pancreas and biliary disease is performed more frequently. Nevertheless, laparoscopic pancreaticoduodenectomy (LPD) is still not performed worldwide because of the complexity of the procedure and high mortality and morbidity. And Evidences on its effectiveness and safety are not confirmed enough. Most of the meta analyses found that LPD were feasible and oncologically safe procedures including 4 RCTs. In this presentation, Evidences for LPD will be reviewed focusing the 4 RCTs, and retrospective data from Korean MIPS on LPD will be presented. As Korean RCT on LPD is just finished enrollment, brief protocol will be presented.